COVID-19 Leads To Less Industry Spend On Docs, But Not Necessarily Less Influence
Executive Summary
Drug and medical device company payments to doctors and hospitals for non-research related activities dropped for the first time in 2020 since CMS’s Open Payments database began collecting the information.